Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Staub

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Infection and Immunity|December 1, 1992
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complexP P Vella, S Marburg, J M Staub, et al.
Pediatrics|April 1, 1990
Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)P P Vella, J M Staub, J Armstrong, et al.
Pediatrics|April 1, 1990
Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluationV I Ahonkhai, L J Lukacs, L C Jonas, et al.
The Pediatric Infectious Disease Journal|August 1, 1993
Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infantsE K Mulholland, V I Ahonkhai, A M Greenwood, et al.
Nature Biotechnology|March 4, 2000
High-yield production of a human therapeutic protein in tobacco chloroplastsJ M Staub, B Garcia, J Graves, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Infection and Immunity|December 1, 1992
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complexP P Vella, S Marburg, J M Staub, et al.
Pediatrics|April 1, 1990
Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)P P Vella, J M Staub, J Armstrong, et al.
Pediatrics|April 1, 1990
Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluationV I Ahonkhai, L J Lukacs, L C Jonas, et al.
The Pediatric Infectious Disease Journal|August 1, 1993
Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infantsE K Mulholland, V I Ahonkhai, A M Greenwood, et al.
Nature Biotechnology|March 4, 2000
High-yield production of a human therapeutic protein in tobacco chloroplastsJ M Staub, B Garcia, J Graves, et al.
Pageof 3